JP2013510814A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013510814A5 JP2013510814A5 JP2012538292A JP2012538292A JP2013510814A5 JP 2013510814 A5 JP2013510814 A5 JP 2013510814A5 JP 2012538292 A JP2012538292 A JP 2012538292A JP 2012538292 A JP2012538292 A JP 2012538292A JP 2013510814 A5 JP2013510814 A5 JP 2013510814A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- hydrogen
- compound represented
- fluoro
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 18
- 229910052739 hydrogen Inorganic materials 0.000 claims description 15
- 239000001257 hydrogen Substances 0.000 claims description 15
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 14
- 125000001153 fluoro group Chemical group F* 0.000 claims description 12
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 125000002971 oxazolyl group Chemical group 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- 125000002883 imidazolyl group Chemical group 0.000 claims description 3
- 125000001786 isothiazolyl group Chemical group 0.000 claims description 3
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 3
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 3
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 3
- 125000000335 thiazolyl group Chemical group 0.000 claims description 3
- 125000001544 thienyl group Chemical group 0.000 claims description 3
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims description 2
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 2
- 125000001246 bromo group Chemical group Br* 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 239000012453 solvate Substances 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 239000002585 base Substances 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 239000002253 acid Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 230000002062 proliferating effect Effects 0.000 claims 3
- PQXJWVWZZGZNBE-VBKFSLOCSA-N (z)-2-anilino-4-phenylbut-2-enenitrile Chemical compound C=1C=CC=CC=1C/C=C(/C#N)NC1=CC=CC=C1 PQXJWVWZZGZNBE-VBKFSLOCSA-N 0.000 claims 2
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 claims 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 2
- 229940126062 Compound A Drugs 0.000 claims 2
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims 2
- -1 chloro, cyano, methyl Chemical group 0.000 claims 2
- 239000012024 dehydrating agents Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 150000004677 hydrates Chemical class 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- 238000007069 methylation reaction Methods 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 1
- 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 125000006163 5-membered heteroaryl group Chemical group 0.000 description 1
- 125000006164 6-membered heteroaryl group Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 125000001072 heteroaryl group Chemical group 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09175642.9 | 2009-11-11 | ||
| EP09175642 | 2009-11-11 | ||
| PCT/EP2010/066983 WO2011069761A1 (en) | 2009-11-11 | 2010-11-08 | Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013510814A JP2013510814A (ja) | 2013-03-28 |
| JP2013510814A5 true JP2013510814A5 (cg-RX-API-DMAC7.html) | 2014-12-25 |
| JP5753182B2 JP5753182B2 (ja) | 2015-07-22 |
Family
ID=43629143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012538292A Expired - Fee Related JP5753182B2 (ja) | 2009-11-11 | 2010-11-08 | フルオロ置換２−アリール−３，５−ジシアノ−４−インダゾリル−６−メチル−１，４−ジヒドロピリジンおよびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9018234B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2499124B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5753182B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102666525B (cg-RX-API-DMAC7.html) |
| CA (1) | CA2777907C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2549132T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011069761A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104513253A (zh) | 2013-10-01 | 2015-04-15 | 南京波尔泰药业科技有限公司 | 用于治疗增殖性疾病的大环化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3635977A (en) | 1969-11-03 | 1972-01-18 | American Cyanamid Co | Certain 6-trifluoromethylcytosines and thiocytosines their synthesis and their use in the synthesis of uracisls and thiouracil |
| EP1720855A4 (en) | 2004-03-02 | 2008-12-17 | Smithkline Beecham Corp | HEMMER OF ACT ACTIVITY |
| EP1828135A4 (en) | 2004-12-13 | 2009-08-12 | Irm Llc | COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROIDAL RECEPTORS AND CALCIUM CHANNEL ACTIVITIES |
| EP1858325A4 (en) | 2005-01-07 | 2010-06-30 | Roskamp Res Llc | COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION AND METHODS FOR IDENTIFYING THESE COMPOUNDS |
| CA2672167C (en) | 2006-12-14 | 2016-01-26 | Bayer Schering Pharma Aktiengesellschaft | Dihydropyridine derivatives useful as protein kinase inhibitors |
-
2010
- 2010-11-08 EP EP10775812.0A patent/EP2499124B1/en not_active Not-in-force
- 2010-11-08 JP JP2012538292A patent/JP5753182B2/ja not_active Expired - Fee Related
- 2010-11-08 ES ES10775812.0T patent/ES2549132T3/es active Active
- 2010-11-08 CN CN201080050319.5A patent/CN102666525B/zh not_active Expired - Fee Related
- 2010-11-08 WO PCT/EP2010/066983 patent/WO2011069761A1/en not_active Ceased
- 2010-11-08 CA CA2777907A patent/CA2777907C/en not_active Expired - Fee Related
- 2010-11-08 US US13/509,047 patent/US9018234B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2842955B1 (en) | Trk-inhibiting compound | |
| TW444013B (en) | Quinoline and quinazoline compounds useful in treating benign prostatic hyperplasia | |
| JP2014508811A5 (cg-RX-API-DMAC7.html) | ||
| JP2007524696A5 (cg-RX-API-DMAC7.html) | ||
| JPWO2000039116A1 (ja) | アミノピラゾール誘導体 | |
| WO2011074658A1 (ja) | 新規抗血小板薬 | |
| JP2014506599A5 (cg-RX-API-DMAC7.html) | ||
| JP2009515988A5 (cg-RX-API-DMAC7.html) | ||
| CA2439758A1 (en) | Substituted 2,6-diamino-3,5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands | |
| JP2006507355A5 (cg-RX-API-DMAC7.html) | ||
| JP6592512B2 (ja) | 三環式アトロプ異性体の化合物 | |
| CA3142069A1 (en) | Aurora kinase inhibitor and use thereof | |
| CA2654315A1 (en) | Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and their use | |
| WO2014200075A1 (ja) | ４－アルキニルイミダゾール誘導体およびそれを有効成分として含有する医薬 | |
| JP2018529690A5 (cg-RX-API-DMAC7.html) | ||
| JP2011509302A5 (cg-RX-API-DMAC7.html) | ||
| JP2013542267A5 (cg-RX-API-DMAC7.html) | ||
| JP7239246B2 (ja) | アンドロゲン受容体調節因子及びグルココルチコイド受容体調節因子としての新規アナログ | |
| JP2013544854A5 (cg-RX-API-DMAC7.html) | ||
| JP2007517007A5 (cg-RX-API-DMAC7.html) | ||
| JP2017532377A5 (cg-RX-API-DMAC7.html) | ||
| JP4450628B2 (ja) | ファルネシルトランスフェラーゼインヒビターとして使用するためのベンジルイミダゾリル置換２−キノリンおよびキナゾリン誘導体 | |
| CA2663903A1 (en) | 3-cyano-5-thiazaheteroaryl-dihydropyridine and the use thereof for the treatment of cardiovascular diseases | |
| JPWO2009041559A1 (ja) | インダゾールアクリル酸アミド化合物 | |
| JP2005502636A5 (cg-RX-API-DMAC7.html) |